TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32151851

Group type: EXPERIMENTAL
Intervention: Calcium channel blocker
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: Angiotensin-converting enzyme inhibitor/angiotensin receptor blocker
Number of subjects: 14

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 14
Study: 34755388

Group type: EXPERIMENTAL
Intervention: Bayesian group-sequential trial design utilizing Multisource Exchangeability Models
Number of subjects: 0

Group type: COMPARATOR
Intervention: Traditional group-sequential design
Number of subjects: 0
Study: 34481551

Group type: EXPERIMENTAL
Intervention: Children with sickle cell disease (HbSS and HbSC) born between 2003 and 2013
Number of subjects: 11186

Group type: EXPERIMENTAL
Intervention: Children with sickle cell disease (HbSS and HbSC)
Number of subjects: 11186

Group type: COMPARATOR
Intervention: National under-5 mortality
Number of subjects: 11186
Study: 32404056

Group type: EXPERIMENTAL
Intervention: 2 L‐PEG solutions with 1 L GT liquids
Number of subjects: 116

Group type: COMPARATOR
Intervention: 2 L‐PEG solutions only
Number of subjects: 116
Study: 34732695

Group type: EXPERIMENTAL
Intervention: Overt SSRI treatment with escitalopram 20 mg
Number of subjects: 27

Group type: COMPARATOR
Intervention: Covert SSRI treatment with escitalopram 20 mg
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Overt SSRI treatment
Number of subjects: 27

Group type: COMPARATOR
Intervention: Covert SSRI treatment
Number of subjects: 27

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 27
Study: 34506311

Group type: EXPERIMENTAL
Intervention: Multimodal analgesia strategies for trauma
Number of subjects: 1561
Study: 32234702

Group type: EXPERIMENTAL
Intervention: Hierarchical Bayesian regression model using 4 days of self-assessment
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Hierarchical Bayesian regression model
Number of subjects: 84

Group type: EXPERIMENTAL
Intervention: Forecasting method
Number of subjects: 84
Study: 35350537

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) intervention including personalized breathing training, small muscle group resistance training, and aerobic endurance training for 5 days.
Number of subjects: 120

Group type: COMPARATOR
Intervention: Attention control group (no specific intervention details provided).
Number of subjects: 120

Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) intervention.
Number of subjects: 120
Study: 33867496

Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control
Number of subjects: 24
Study: 34057186

Group type: EXPERIMENTAL
Intervention: Special Intervention
Number of subjects: 456

Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 456
Study: 32041601

Group type: EXPERIMENTAL
Intervention: Ensifentrine 0.75 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ensifentrine 1.5 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ensifentrine 3 mg
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ensifentrine 6 mg
Number of subjects: 405

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 405

Group type: EXPERIMENTAL
Intervention: Ensifentrine (all doses)
Number of subjects: 405
Study: 34581219

Group type: EXPERIMENTAL
Intervention: Lenvatinib
Number of subjects: 1455

Group type: COMPARATOR
Intervention: Atezolizumab plus Bevacizumab
Number of subjects: 1455
Study: 34019026

Group type: EXPERIMENTAL
Intervention: Combined intervention group (n = 34)
Number of subjects: 101

Group type: EXPERIMENTAL
Intervention: Breathing exercise group (n = 32)
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (n = 35)
Number of subjects: 101
Study: 36054245

Group type: COMPARATOR
Intervention: FiO2 ≥ 0.50 (group H)
Number of subjects: 191

Group type: EXPERIMENTAL
Intervention: FiO2 0.21 (group N)
Number of subjects: 191
Study: 33906631

Group type: EXPERIMENTAL
Intervention: LOCK sleep intervention
Number of subjects: 27
Study: 35225536

Group type: EXPERIMENTAL
Intervention: Caffeine intake
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 120
Study: 33612360

Group type: EXPERIMENTAL
Intervention: Ferric derisomaltose 20 mg/kg
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Ferric derisomaltose
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: Intravenous iron
Number of subjects: 102
Study: 32885518

Group type: EXPERIMENTAL
Intervention: Reminiscence therapy (RT) intervention
Number of subjects: 56

Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 56
Study: 33499668

Group type: EXPERIMENTAL
Intervention: Catheter ablation with pulmonary vein isolation
Number of subjects: 2204

Group type: COMPARATOR
Intervention: Drug therapy with rate/rhythm control agents
Number of subjects: 2204

Group type: EXPERIMENTAL
Intervention: Catheter ablation
Number of subjects: 2204

Group type: COMPARATOR
Intervention: Drug therapy
Number of subjects: 2204
Study: 32460748

Group type: EXPERIMENTAL
Intervention: Interactive web-based intervention
Number of subjects: 400

Group type: COMPARATOR
Intervention: Web-based information without sexual health components
Number of subjects: 400
Study: 35793698

Group type: EXPERIMENTAL
Intervention: Inpatient portal use
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Outpatient portal use
Number of subjects: 654

Group type: EXPERIMENTAL
Intervention: Post-discharge portal use assessment
Number of subjects: 654
Study: 34191090

Group type: EXPERIMENTAL
Intervention: Tourniquet
Number of subjects: 154

Group type: COMPARATOR
Intervention: No-tourniquet
Number of subjects: 154
Study: 32153038

Group type: EXPERIMENTAL
Intervention: Occlusal Splint (OS)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Manual Therapy (MT)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Counselling (CS)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Combination of Occlusal Splint and Counselling (OSCS)
Number of subjects: 89

Group type: COMPARATOR
Intervention: All groups (OS, MT, CS, OSCS)
Number of subjects: 89
Study: 34597743

Group type: EXPERIMENTAL
Intervention: Imagery of giving 30 M&Ms to children
Number of subjects: 92

Group type: COMPARATOR
Intervention: Imagery of eating 30 M&Ms
Number of subjects: 92

Group type: COMPARATOR
Intervention: Imagery of sorting 30 marbles
Number of subjects: 92
Study: 35675228

Group type: EXPERIMENTAL
Intervention: Information designed to correct misperceptions of gun owner support for gun safety policies
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control information
Number of subjects: 0
Study: 32813887

Group type: EXPERIMENTAL
Intervention: GRAZAX® (sublingual immunotherapy) for 2 years
Number of subjects: 47

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 47
Study: 35058417

Group type: EXPERIMENTAL
Intervention: HP‐guar/nanoemulsion
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: HP‐guar/HA
Number of subjects: 24

Group type: COMPARATOR
Intervention: Saline alone
Number of subjects: 24
Study: 33049220

Group type: EXPERIMENTAL
Intervention: Ultrasound-guided transversus abdominis plane (TAP) block
Number of subjects: 18

Group type: COMPARATOR
Intervention: Control group (without TAP block)
Number of subjects: 18
Study: 35084724

Group type: EXPERIMENTAL
Intervention: Salbutamol plus budesonide nebulizer (budesonide 0.5 mg nebulized three times for 20 minutes)
Number of subjects: 228

Group type: COMPARATOR
Intervention: Salbutamol nebulizer alone
Number of subjects: 228

Group type: EXPERIMENTAL
Intervention: Salbutamol plus budesonide nebulizer
Number of subjects: 228
Study: 33572946

Group type: EXPERIMENTAL
Intervention: Physical Activity and Sport for Acquired Brain Injury (PASABI) program (1-hour sessions, 2-4 sessions/week for 18 weeks)
Number of subjects: 73

Group type: COMPARATOR
Intervention: Standard rehabilitation program without physical activity (Control Group)
Number of subjects: 73
Study: 32517453

Group type: EXPERIMENTAL
Intervention: Da Vinci robotic radical lung cancer surgery with chest wall external nursing interventions
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Da Vinci robotic radical lung cancer surgery with chest wall external nursing interventions for patients with chest wall thickness < 4 cm
Number of subjects: 0

Group type: COMPARATOR
Intervention: Robotic radical lung cancer resection with abdominal bands wrapped around the chest (Control Group)
Number of subjects: 0
Study: 35622269

Group type: EXPERIMENTAL
Intervention: Active ZIDA® activation device (ZIDA)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Sham control group (SCG)
Number of subjects: 40
Study: 33272959

Group type: EXPERIMENTAL
Intervention: Non-surgical treatment
Number of subjects: 190

Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 190
Study: 34426445

Group type: EXPERIMENTAL
Intervention: Yearly assessment by the GP of 8 geriatric syndromes with a tailored management plan
Number of subjects: 429

Group type: COMPARATOR
Intervention: Routine care
Number of subjects: 429
Study: 35415998

Group type: EXPERIMENTAL
Intervention: CHO+PRO (0.75+0.25g·BW‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: CHO (1.0g·BW‐1)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo control
Number of subjects: 10
Study: 32319341

Group type: EXPERIMENTAL
Intervention: Psychoeducation program based on Human Caring Theory
Number of subjects: 24

Group type: COMPARATOR
Intervention: Antenatal education classes
Number of subjects: 24
Study: 32332464

Group type: EXPERIMENTAL
Intervention: Ketamine 0.1 mg/kg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ketamine 0.2 mg/kg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ketamine 0.5 mg/kg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Ketamine 1.0 mg/kg
Number of subjects: 99

Group type: COMPARATOR
Intervention: Active placebo, midazolam 0.045 mg/kg
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Obese category (BMI)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Overweight category (BMI)
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Reference group (not obese/overweight)
Number of subjects: 99
Study: 34031723

Group type: EXPERIMENTAL
Intervention: Dual autonomic blockade (DAB) with 0.04 mg/kg atropine and 0.2 mg/kg metoprolol
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: Dual autonomic blockade (DAB)
Number of subjects: 29

Group type: COMPARATOR
Intervention: Non-EOV group (control)
Number of subjects: 29

Group type: EXPERIMENTAL
Intervention: EOV group
Number of subjects: 29
Study: 32338944

Group type: EXPERIMENTAL
Intervention: Physical activity intervention (aerobic or resistance training)
Number of subjects: 86

Group type: COMPARATOR
Intervention: Balance and tone control group
Number of subjects: 86
Study: 36449873

Group type: EXPERIMENTAL
Intervention: Macrophage-activating gel
Number of subjects: 42

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 42
Study: 34083345

Group type: EXPERIMENTAL
Intervention: ERAS protocol management
Number of subjects: 2200

Group type: COMPARATOR
Intervention: Standard perioperative management
Number of subjects: 2200
Study: 35554270

Group type: EXPERIMENTAL
Intervention: Hot Water Immersion (HWI)
Number of subjects: 6

Group type: COMPARATOR
Intervention: Aerobic Exercise Training (EX)
Number of subjects: 6
Study: 36087699

Group type: EXPERIMENTAL
Intervention: Specific psychotherapeutic intervention (SEKT)
Number of subjects: 59

Group type: COMPARATOR
Intervention: Emotion-focused intervention (FEST)
Number of subjects: 59
Study: 33446227

Group type: EXPERIMENTAL
Intervention: Triheptanoin
Number of subjects: 12
Study: 32679597

Group type: EXPERIMENTAL
Intervention: Thrombolysis
Number of subjects: 820

Group type: COMPARATOR
Intervention: Anticoagulation
Number of subjects: 820
Study: 36204784

Group type: EXPERIMENTAL
Intervention: Molecular hydrogen (H2) at a concentration of 1.5-2.0% through a facemask during surgery
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group (no H2 exposure)
Number of subjects: 24
Study: 34759686

Group type: EXPERIMENTAL
Intervention: 0.12% chlorhexidine (CHX)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: 0.75% boric acid (BA)
Number of subjects: 90

Group type: COMPARATOR
Intervention: water (Control)
Number of subjects: 90
Study: 34902373

Group type: EXPERIMENTAL
Intervention: Wide-area transepithelial sampling (WATS)
Number of subjects: 1002

Group type: COMPARATOR
Intervention: Forceps biopsy sampling (FB)
Number of subjects: 1002

Group type: EXPERIMENTAL
Intervention: Both WATS and FB
Number of subjects: 1002
Study: 33400206

Group type: EXPERIMENTAL
Intervention: Women's Stories (WS) intervention
Number of subjects: 217

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 217
Study: 34819070

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Accessible Care (AC)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Pre-COVID-19 sample
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: COVID-19 sample
Number of subjects: 106
Study: 33045675

Group type: EXPERIMENTAL
Intervention: Chromium picolinate (400 mcg/day)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 46
Study: 33357708

Group type: EXPERIMENTAL
Intervention: APS pretreatment (0.6 g/L)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Control (drinking water)
Number of subjects: 190
Study: 35983959

Group type: EXPERIMENTAL
Intervention: Active THC cigarette (26.25 mg/2.7% THC)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo marijuana cigarette (0.002% THC)
Number of subjects: 24
Study: 33683710

Group type: EXPERIMENTAL
Intervention: Midazolam (2 mg)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Dexamethasone (8 mg) and Ondansetron (4 mg)
Number of subjects: 120
Study: 32321115

Group type: EXPERIMENTAL
Intervention: Warming group (fluid warmer at 41°C)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control group (warming blanket at 43°C)
Number of subjects: 108
Study: 35211831

Group type: COMPARATOR
Intervention: Postoperative modified FOLFOX6
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Perioperative modified FOLFOX6 plus cetuximab
Number of subjects: 77
Study: 34960060

Group type: EXPERIMENTAL
Intervention: Low energy-dense ready meal (LEDRM)
Number of subjects: 26

Group type: COMPARATOR
Intervention: High energy-dense ready meal (HEDRM)
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: LEDRM
Number of subjects: 26
Study: 32584973

Group type: EXPERIMENTAL
Intervention: PCV13
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Non-typeable isolates
Number of subjects: 0
Study: 35491736

Group type: EXPERIMENTAL
Intervention: Dual users of combustible and electronic cigarettes
Number of subjects: 2896
Study: 33011864

Group type: EXPERIMENTAL
Intervention: Fluticasone furoate/umeclidinium/vilanterol (FF/UMEC/VI)
Number of subjects: 406
Study: 33607119

Group type: EXPERIMENTAL
Intervention: Auricular acupressure
Number of subjects: 177

Group type: EXPERIMENTAL
Intervention: Auricular acupuncture
Number of subjects: 177

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 177
Study: 33256697

Group type: EXPERIMENTAL
Intervention: Structured-educational intervention on HPV
Number of subjects: 506
Study: 33296455

Group type: EXPERIMENTAL
Intervention: 7-day changes
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 10-day changes
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: 14-day changes
Number of subjects: 80

Group type: COMPARATOR
Intervention: Comparison of 7-day and 14-day protocols
Number of subjects: 80
Study: 32280093

Group type: EXPERIMENTAL
Intervention: atDCS (1:mA, right temporoparietal cortex) combined with visuospatial OLM training
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham atDCS (30:s) combined with visuospatial OLM training
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: atDCS (1:mA)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Sham atDCS
Number of subjects: 48
Study: 35351134

Group type: EXPERIMENTAL
Intervention: Biocan DHPPi+L (Bioveta, Czech)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Duramune Max 5 + LCI / GP (Fort Dodge Animal Health, USA)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Physiological serum (Control group)
Number of subjects: 24
Study: 34831608

Group type: EXPERIMENTAL
Intervention: Squatting with Whole-Body Vibration (WBV)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Squatting without Whole-Body Vibration (Control)
Number of subjects: 40
Study: 32815175

Group type: EXPERIMENTAL
Intervention: Continuous monitoring procedure accommodating time trends in event rates
Number of subjects: 0

Group type: COMPARATOR
Intervention: Monitoring procedure assuming constant rates
Number of subjects: 0
Study: 35818125

Group type: EXPERIMENTAL
Intervention: 8-week telephone counseling with nicotine replacement
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: 3-week telephone counseling with nicotine replacement
Number of subjects: 0

Group type: COMPARATOR
Intervention: Screening alone
Number of subjects: 0
Study: 33683065

Group type: EXPERIMENTAL
Intervention: Interferon gamma (IFN‐γ) 500,000 IU administered subcutaneously, daily for 5 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Complex therapy of the disease (control group not explicitly mentioned)
Number of subjects: 0
Study: 35810063

Group type: EXPERIMENTAL
Intervention: Quadrivalent subunit influenza vaccine (single dose, with a boosting dose at day 28 for children aged 3–8 years)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Split‐virion influenza vaccine (control group)
Number of subjects: 0
Study: 33071199

Group type: EXPERIMENTAL
Intervention: Sealed road simulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Cross-country simulation
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Restricted posture simulation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 60
Study: 35538687

Group type: EXPERIMENTAL
Intervention: Application-based antenatal education based on social cognitive theory (SCT)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Conventional pregnancy class (Control)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: Application-based antenatal education based on SCT
Number of subjects: 145
Study: 32067871

Group type: EXPERIMENTAL
Intervention: Practice facilitation intervention with at least 13 practice visits over 1 year
Number of subjects: 257
Study: 35734824

Group type: EXPERIMENTAL
Intervention: Precision-medicine approach (comprehensive diagnostic workup and pharmacological treatment specific for the underlying cause)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Standard of care (routine diagnostic workup and standard medical treatment for acute coronary syndrome)
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Precision-medicine approach
Number of subjects: 180
Study: 35151522

Group type: EXPERIMENTAL
Intervention: d-DPP (n=299)
Number of subjects: 599

Group type: COMPARATOR
Intervention: Control (single-session small-group diabetes-prevention education class, n=300)
Number of subjects: 599
Study: 33213976

Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000 units every two weeks for six months
Number of subjects: 108

Group type: COMPARATOR
Intervention: Placebo every two weeks for six months
Number of subjects: 108
Study: 32308190

Group type: EXPERIMENTAL
Intervention: Calories, Sodium + CS
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Calories + CS
Number of subjects: 998

Group type: EXPERIMENTAL
Intervention: Calories and Sodium in Traffic Lights + CS
Number of subjects: 998

Group type: COMPARATOR
Intervention: No Nutrition Information
Number of subjects: 998
Study: 35392074

Group type: EXPERIMENTAL
Intervention: Revaccination with BCG Moscow
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unvaccinated group
Number of subjects: 0
Study: 34523074

Group type: EXPERIMENTAL
Intervention: Roxadustat
Number of subjects: 4714

Group type: COMPARATOR
Intervention: Erythropoiesis-stimulating agents (ESAs)
Number of subjects: 4714
Study: 33480271

Group type: EXPERIMENTAL
Intervention: Curcumin (500 mg)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study: 33802219

Group type: EXPERIMENTAL
Intervention: Dietary supplement (DS) containing Octacosanol (20 mg) and vitamin K2 (45 µg)
Number of subjects: 87

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 87
Study: 32471478

Group type: EXPERIMENTAL
Intervention: Disclosure decision aid tool (CORAL.NL) and workplace stigma-awareness training for employment specialists
Number of subjects: 0

Group type: COMPARATOR
Intervention: Support as usual from employment specialists
Number of subjects: 0
Study: 35581399

Group type: EXPERIMENTAL
Intervention: Remote ischemic conditioning (RIC)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham-RIC
Number of subjects: 50
Study: 33895622

Group type: EXPERIMENTAL
Intervention: Deep learning model for lung cancer risk assessment
Number of subjects: 10997

Group type: EXPERIMENTAL
Intervention: Deep learning model
Number of subjects: 10997
Study: 35253599

Group type: EXPERIMENTAL
Intervention: Static lumbar foramen opening protocol using flexion and contralateral lateral flexion (side‐lying)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Control group (forward bending, walking, and medication)
Number of subjects: 20
Study: 35367876

Group type: EXPERIMENTAL
Intervention: Naming treatment (modified semantic feature analysis)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Non-naming treatment (auditory comprehension, copying text, and reading)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 17
Study: 34228613

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA) 15 mg/kg in 100 ml saline solution administered 20 minutes before the end of surgery
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group received 100 ml saline solution without TXA
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Intravenous tranexamic acid (TXA)
Number of subjects: 0
Study: 32205478

Group type: EXPERIMENTAL
Intervention: His bundle pacing (HBP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Biventricular pacing (BiV)
Number of subjects: 0
Study: 35403756

Group type: EXPERIMENTAL
Intervention: Specific collagen peptides (SCP)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo (PLA)
Number of subjects: 40
Study: 34110840

Group type: EXPERIMENTAL
Intervention: BASICCS (Brief Alcohol Screening and Intervention for College Students)
Number of subjects: 142

Group type: COMPARATOR
Intervention: Assessment-Only Control (AOC)
Number of subjects: 142
Study: 35088079

Group type: EXPERIMENTAL
Intervention: Guided self-help mindfulness-based interventions (GSH-MBIs)
Number of subjects: 122

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 122